Research programme: antioxidants - Resdevco
Latest Information Update: 16 Jul 2016
At a glance
- Originator Resdevco
- Class
- Mechanism of Action Antioxidants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Retinal disorders; Unspecified
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Retinal-disorders in Israel
- 16 Jul 2016 No recent reports of development identified for preclinical development in Undefined in Israel
- 23 May 2006 Preclinical trials in Retinal disorders in Israel (unspecified route)